Pulmonary embolism is the third most common cause of death from cardiovascular disease
after heart attack and stroke. Sequelae occurring after venous thromboembolism include …

Deep vein thrombosis and pulmonary embolism, collectively referred to as venous
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …

Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

Pulmonary embolism is the third most common cardiovascular disease after myocardial
infarction and stroke. The death rate from pulmonary embolism exceeds the death rate from …

Venous thromboembolism (VTE) is categorised as deep venous thrombosis (DVT) and
pulmonary embolism (PE). VTE is associated with high morbidity and causes a huge …

This guidance document focuses on the diagnosis and treatment of venous
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …

Venous thromboembolism (VTE) is a common condition that can lead to complications such
as postphlebitic syndrome, chronic pulmonary artery hypertension, and death. The approach …

Making a diagnosis of deep vein thrombosis (DVT) requires both clinical assessment and
objective testing because the clinical features are nonspecific and investigations can be …

Importance Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a common and potentially fatal disease. Objective To …

To assess the state of the art of venous thrombosis and pulmonary embolism for the medical
and other health-related professions, the World Health Organization (WHO) and the …